Are you searching for medications to treat 'Antipsychotic Medications'? Welcome to this page which serves as an archive for medications that are relevant to the treatment of Antipsychotic Medications.

If you are prescribed an antipsychotic medication, please consider finding a therapist you trust to help you learn more about what you are experiencing and to help you develop coping strategies to ...

Antipsychotic drugs may be prescribed for people with dementia who develop changes such as aggression and psychosis. However this is usually only after other drugs have been tried such as ...

People with these symptoms are often prescribed antipsychotic drugs inappropriately. These may reduce experiences such as delusions, but they are also linked to serious side effects including ...

Psychotropic medications are drugs that affect the mind, emotions, and behavior. The broad categories of psychotropic ...

Recently, second-generation antipsychotics (SGAs), olanzapine plus fluoxetine, quetiapine extended release and aripiprazole have clearly demonstrated efficacy in the treatment of MDD patients ...

Management of adverse events is a major concern of clinicians who use antipsychotic drugs. The incidence of motor side effects is dose dependent. Atypical antipsychotic drugs are less likely to ...

More recent data from NHS Digital shows, in October 2019, the proportion of patients with a recorded diagnosis of dementia who had a prescription of antipsychotic medication in the previous 6 weeks ...

Insurer access challenges likely lie ahead for the novel schizophrenia drug Cobenfy, given its considerably higher price than ...

The US Food and Drug Administration (FDA) is poised to regulate a "potential first-in-class antipsychotic", known as KarXT, said Medscape. About one in 300 people worldwide are affected by ...

He was responsible for launching the company’s last major drug to treat schizophrenia, the antipsychotic Abilify, in 2002. Cobenfy, set to launch in October, will have a list price that would ...

The worldwide growing occurrences of mental health disorders are significantly boosting the antipsychotic drugs market. An estimated 21% of U.S. adults have mental illness in 2023, which is over ...